News

Drugmaker telehealth deals risk unnecessary prescribing, Senate probe finds
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.
Zacks Investment Research on MSN3h
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...
Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been fil ...
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors To Secure Counsel Before Important Deadline In Securities Class Action HIMS
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive ...
USA Herald7h
Hims & Hers Executives Face Lawsuit Over Knockoff Wegovy Sales
Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...
The Daily Reflector19h
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the ...